CD16 Antikörper
-
- Target Alle CD16 Antikörper anzeigen
- CD16
-
Reaktivität
- Human, Affe
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CD16 Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS), Immunoprecipitation (IP), Immunohistochemistry (IHC)
- Spezifität
-
The mouse monoclonal antibody 3G8 recognizes CD16, a low affinity receptor for aggregated IgG (FcgammaRIII antigen). CD16 exists in two different isoforms: CD16a (FcgammaRIIIA, 50-65 kDa, expressed on NK-cells, monocytes and macrophages) and CD16b (FcgammaRIIIB, 48 kDa, mainly expressed on neutrophils).
HLDA V, WS Code NK80
- Aufreinigung
- Purified from hybridoma culture supernatant by protein-A affinity chromatography
- Immunogen
- Human neutrophils.
- Isotyp
- IgG1
- Top Product
- Discover our top product CD16 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Azide free phosphate buffered saline (PBS), approx. pH 7.4, 0.2 μm filter sterilized. Endotoxin level is less than 0.01 EU/μg of the protein, as determined by the LAL test.
- Konservierungsmittel
- Azide free
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Store at 2-8°C. Do not freeze.
-
- Target
- CD16
- Andere Bezeichnung
- CD16 (CD16 Produkte)
- Synonyme
- Fcgr3 antikoerper, Fcgr3a antikoerper, CD16 antikoerper, FCGR3 antikoerper, FCGR3@ antikoerper, CD16b antikoerper, FCG3 antikoerper, FCR-10 antikoerper, FCRIII antikoerper, FCRIIIb antikoerper, FcRIII antikoerper, Fc fragment of IgG, low affinity IIa, receptor antikoerper, Fc fragment of IgG, low affinity IIIa, receptor (CD16a) antikoerper, Fc fragment of IgG receptor IIIb antikoerper, Fc fragment of IgG receptor IIIa antikoerper, Fc receptor, IgG, low affinity III antikoerper, Fc-gamma RIII antikoerper, Fcgr2a antikoerper, FCGR3A antikoerper, FCGR3B antikoerper, Fcgr3 antikoerper, FCGR3 antikoerper
- Gen-ID
- 2214
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-